COVID-19 Clinical Forum 2021

The COVID-19 Clinical Forum 2021 was a series of 8 online interactive meetings (90 minutes each) that provided continuing education to a wide range of healthcare professionals, including infectious disease doctors, pulmonologists, and virologists, among others. The program encompassed a broad range of topics, from COVID-19 epidemiology, treatments, post-COVID conditions & clinical manifestations, clinical management, pathophysiology, prevention, vaccines, diagnostics, and public health strategies.

This EACCMED-accredited program was continuously updated as new information emerges and provides the latest COVID-19 data from renowned experts to clinicians worldwide. This program was designed to provide state-of-the-art, concise and comprehensive lectures, and to facilitate participation from healthcare professionals from around the world.

The program encompassed a wide range of topics, from vaccine research, immune response, SARS CoV-2 infection, diagnostics, and the use of artificial intelligence to contain the spread of the virus, to clinically orientated lectures on the emerging treatment options and novel insights into disease pathophysiology.

The series will include continuous updates on COVID-19 infection control, epidemiology, prevention, diagnosis, pathogenesis, pathophysiology, clinical manifestations and management, emerging variants, therapeutic options, vaccine development and Implementation, public health measures, and treatments.

• Health care providers involved in the care of SARS-CoV2 infected patients;
• Infectious disease clinicians;
• Clinical virologists;
• Primary care physicians;
• Intensivists;
• Microbiologists; and
• Specialized nurses.

MSD and GSK have both provided part funding for this Independent Medical Education program.

MSD and GSK have had no input into selection of speakers or the content of the materials and presentations.